As a student, his journey started with a dream: "Working for a growing biotech company." What ensued exceeded his expectations and resulted in a pivotal change that defined his career. “QIAGEN was my employer of choice. I always wanted to know more about less. That led me to HID,” says Christian Starke, our senior technical sales manager for HID & Forensics. Over twenty years, Christian was the first member of the forensic team, which grew to 100 people and gained our customers' trust. His motivation for working in forensics has always been fighting crime. Twenty-eight years have passed since Christian first dreamed about his career. After years of hard work, networking, and fighting crime, he is now preparing for retirement. We are proud to have had Christian on our team and wish him all the best in his next chapter, where he will pursue his passions for music, art, and wildlife conservation.
Om oss
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.
- Webbplats
-
http://www.qiagen.com
Extern länk för QIAGEN
- Bransch
- Forskning inom bioteknik
- Företagsstorlek
- 5 001–10 000 anställda
- Huvudkontor
- Venlo, Limburg
- Typ
- Publikt aktiebolag
- Specialistområden
- Life science research, Molecular diagnostics, Applied testing (forensics, food safety testing, veterinary medicine), Pharmaceutical research och bioinformatics
Adresser
Anställda på QIAGEN
Uppdateringar
-
🎉 Guess what day it is? It's August 1, which means it's RNA Day! ✅ RNA plays an important role in translating genetic information. We all know the central dogma – #DNA ➡ #RNA ➡ protein. However, some RNAs have other unique functions, like miRNAs. On this day, we're putting the spotlight on miRNA research. ✅ To celebrate, we've got some special gifts in store for you. If you want to grab one, test your knowledge of #miRNA. Learn more 👉 https://lnkd.in/esMqg7zb
Innehållet är inte tillgängligt här
Få tillgång till det här innehållet och mycket mer i LinkedIns app
-
We exceeded our outlook and delivered a solid performance in Q2 2024. Learn more 👉 https://lnkd.in/gUgiiuin ◾ Q2 2024: Net sales of $496 million (+0% actual rates, +1% constant exchange rates, CER); net loss per share of $0.83 but adjusted diluted EPS of $0.55. ➡ Net sales at CER of $502 million ahead of outlook for at least $495 million CER and adjusted diluted EPS of $0.55 CER ahead of $0.52 CER outlook. ➡ 28.4% adj. operating income margin up 1 percentage point from 27.4% in Q2 2023. ➡ Q2 2024 free cash flow up 56% to $129 million vs. Q2 2023. ◾ FY 2024 outlook updated after solid H1 2024 results ahead of outlook. ➡ Updated net sales outlook of at least $1.985 billion CER reflects solid core business trends and NeuMoDx decision. ➡ Adj. diluted EPS outlook increased to at least $2.16 CER.
-
-
When Riccardo Alagna, our Associate Director of Medical Affairs, was climbing Mont Blanc, he had one goal in mind: raising awareness and funds to support #tuberculosis prevention! The ascent was a symbol of resilience for him, mirroring the determination #TB patients must exhibit when they begin their six-month treatment journey. Read more about Riccardo's story and learn how he is making an impact to prevent TB both in Italy and abroad. 👉 https://lnkd.in/eq-cZ6X4
-
-
“I hear mooing sometimes if I have my (office) window open.” Meet Ashley and Jamie Spychalla: The first two summer interns from our collaboration with One Health Microbiome Center at Penn State. They’ve taken some time off their normal work on the benefits of sourdough microbes and pathological microbiomes in grapes to perform projects with our product development teams. What surprised them the most? The familiarity of the research and how well skills they’ve learned in academia transferred to product development. Also, how large our campus and production facilities in Hilden are, the diversity of the workforce and the many different professions mingling in the cafeteria. What left the deepest impressions? The German concept of “Gastfreundschaft” (being a good host), how warm and welcoming the QIAGENers were from the first day on, and, oh yeah, the regional farm next to our offices.
-
-
It was a pleasure for our QIAGEN Manchester team to host for a visit Sir Patrick Vallance, the Minister for the Department for Science, Innovation and Technology of the United Kingdom. During the visit, Sir Patrick toured the facility and met with our team, who provided an overview of our latest innovations and strategic initiatives – all aligned with advancing #science and improving #healthcare. He took a deep interest in the products, especially our QIAcuity digital PCR platform and the expanding range of applications, as well as the role of companion diagnostics and their potential to make a difference in improving outcomes for patients with cancer as well as chronic and hereditary diseases. This visit of such a high-ranking UK government official was a great opportunity to show how QIAGEN is achieving our vision of making improvements in life possible.
-
-
🤔 If you have ever asked yourself how to be more sustainable in the lab, then we have an answer for you: Reduce, Reuse, and Recycle! ✅ Watch this video and join Nathan Susnik, PhD, one of our senior content managers, as he shows you how, with one tiny snap of the fingers, you can change so much!
-
The human body has trillions of microbes aiding digestion, boosting immunity, and influencing metabolism. So why not the same for plants and soil? Learn how manipulating plant microbiomes can help crop security 👉 https://lnkd.in/efbZTcBf
-
-
🎉 We are excited to share that QIAGEN LLC has been recognized as a Best Place to Work for Disability Inclusion by the Disability Equality Index, receiving a top score! ✅ The Disability Equality Index is widely acknowledged as the most comprehensive assessment tool that helps companies build a roadmap of measurable and tangible actions toward disability inclusion and equality. The Index measures a range of criteria for disability inclusion, all of which are reflected at QIAGEN LLC and throughout our global QIAGEN organization. 🤝 Many thanks to all QIAGENers, who continuously work to create an inclusive and welcoming environment for all employees, ensuring everyone has an equal opportunity to thrive and make a difference!
-
-
Whole genome sequencing of tuberculosis with no cell culture. Learn more 👉 https://lnkd.in/edtezyx7 Yes, it’s true, so we’ll say it again. The new QIAseq xHYB Mycobacterium tuberculosis Panel is designed using the seven major lineages of MTB and provides coverage of all AMR markers with no cell culture.
Anslutna sidor
Liknande sidor
Stock
QGEN
NYSE
20 minutes delay
45,27 US$
0,38 (0,847%)
- Open
- 44,42
- Low
- 44,28
- High
- 45,32
Data from Refinitiv
See more info onFinansiering
QIAGEN
1 runda totalt
Se mer info på crunchbase
Senaste finansieringsrunda
Anslag
Extern Crunchbase Link för sista finansieringsrundan
4 000 000,00 US$